Oksaliplatin Teva (Oxaliplatin)

Oxaliplatin, the active ingredient in Oksaliplatin Teva, is a platinum‑based chemotherapy agent presented as a sterile solution for intravenous infusion use. It is employed in the treatment of colorectal cancer, typically in combination regimens for adult patients. GNH USA supplies Oksaliplatin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Oksaliplatin Teva is a platinum‑based chemotherapeutic that interferes with DNA replication across several cancer‑related pathways. - Colorectal cancer: enhances the efficacy of combination regimens, helping to shrink tumours and prolong survival. - Gastric cancer: used in multimodal treatment protocol to reduce tumour burden and support surgical outcomes. - Pancreatic but but but but but ...   -  ...